CXCL16 and tauopathy: In the future, it would be interesting to investigate whether the pharmacological blockage of the CXCL16-CXCR6 pathway could reduce the microglia-mediated T cell trafficking in the brain and mitigate the neurodegeneration associated with tauopathy in animal and human neuroimmune axis models6,7.